Projected Growth in $3 Billion Parkinson's Treatment Market Gives Rainbow BioSciences, LLC a Bright Outlook
NOKOMIS, Fla.--(BUSINESS WIRE)--The market for effective new treatments for Parkinson’s disease and other degenerative neurological disorders is strong and projected to grow sharply in coming years. That’s good news for Rainbow Coral Corp.’s (OTCBB: RBCC) biotech subsidiary, Rainbow Biosciences, as it closes in on a deal with Amarantus Biosciences, Inc. (OTCBB: AMBS)